Searcharxiv⌕ Search

arXiv subjects

Alejandro Giraldo

Publications and source records attributed to Alejandro Giraldo.

4 recordsLinked to original sources

Quantum-Enhanced QSAR for DYRK1A: Evaluating Complementary and Utility QPU-Derived Molecular Representations

In drug discovery, hit identification selects a limited set of compounds for experimental evaluation from a larger collection of candidates. Because laboratory screening capacity is limited, that choice determines which chemical series continue into further investigation. A hit that is not assayed does not enter confirmation or the analog series, and that chemical series is not opened. For the DYRK1A kinase, the same test molecules were scored from a tabular representation of molecular descriptors and from a vector measured on a quantum processor, with the same RBF-SVM. The question is whether the two models propose the same set for experimental evaluation: they propose different compounds. The model on the vector measured on the quantum processor includes compounds that the tabular representation leaves out, and among them are already-labeled actives. The tabular representation includes actives that the vector measured on the quantum processor leaves out. What is reported is that set: who enters, with what label, and whether published chemistry already mentions it. No formal quantum advantage is claimed, nor a mechanism for why the two vectors separate differently. Those compounds fall within the neighborhood that both representations already cover; what changes is which model marks them active. From that follows the cost of predictive disagreement: each model would send a different chemical series to experimental evaluation.

quant-ph↗

$\mathtt{Q^2SAR}$: overcoming classical bottlenecks in drug discovery via quantum multiple kernel learning

Quantitative Structure-Activity Relationship ($\mathtt{QSAR}$) modeling is a foundational computational methodology in early-stage drug discovery, heavily relied upon for predicting compound toxicity, bioavailability, and therapeutic potential. However, classical methods often struggle to effectively map the highly complex, non-linear, and high-dimensional interactions inherent in molecular data, leading to reduced predictive accuracy and costly late-stage clinical failures. In this paper, we present a Quantum Multiple Kernel Learning ($\mathtt{QMKL}$) framework, dubbed Next-Gen $\mathtt{Q^2SAR}$, that leverages Quantum Support Vector Machines ($\mathtt{QSVMs}$) to overcome these classical limitations. By encoding molecular descriptors into exponentially large quantum Hilbert spaces, our approach substantially enhances the expressiveness of non-linear modeling. Benchmarking our quantum-enhanced framework on a dataset targeting the $\mathtt{DYRK1A}$ kinase (a critical target for Alzheimer's disease), the $\mathtt{QMKL}$-$\mathtt{SVM}$ achieves an impressive Area Under the Curve ($\mathtt{AUC}$) score of $0.8750$, significantly outperforming classical state-of-the-art Gradient Boosting models ($\mathtt{AUC} = 0.8037$). Furthermore, we establish a theoretical and empirical pathway toward resolving classical data bottlenecks through projected quantum kernels ($\mathtt{PQK}$) and measurement accelerators. As quantum computing architecture matures, this framework paves the way for autonomous cognitive architectures and self-improving drug discovery pipelines, promising to unlock deeper insights across vast chemical spaces and to accelerate the development of life-saving therapeutics.

quant-ph↗

Q2SAR: A Quantum Multiple Kernel Learning Approach for Drug Discovery

Quantitative Structure-Activity Relationship (QSAR) modeling is a cornerstone of computational drug discovery. This research demonstrates the successful application of a Quantum Multiple Kernel Learning (QMKL) framework to enhance QSAR classification, showing a notable performance improvement over classical methods. We apply this methodology to a dataset for identifying DYRK1A kinase inhibitors. The workflow involves converting SMILES representations into numerical molecular descriptors, reducing dimensionality via Principal Component Analysis (PCA), and employing a Support Vector Machine (SVM) trained on an optimized combination of multiple quantum and classical kernels. By benchmarking the QMKL-SVM against a classical Gradient Boosting model, we show that the quantum-enhanced approach achieves a superior AUC score, highlighting its potential to provide a quantum advantage in challenging cheminformatics classification tasks.

quant-ph↗

Quantum QSAR for drug discovery

Quantitative Structure-Activity Relationship (QSAR) modeling is key in drug discovery, but classical methods face limitations when handling high-dimensional data and capturing complex molecular interactions. This research proposes enhancing QSAR techniques through Quantum Support Vector Machines (QSVMs), which leverage quantum computing principles to process information Hilbert spaces. By using quantum data encoding and quantum kernel functions, we aim to develop more accurate and efficient predictive models.

quant-ph↗